Taipei Exchange - Delayed Quote TWD

G&E Herbal Biotechnology Co., Ltd. (4911.TWO)

54.10
-0.60
(-1.10%)
At close: June 6 at 1:30:13 PM GMT+8
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
273,766
249,033
181,443
64,607
24,571
Cost of Revenue
45,652
43,689
36,856
25,253
14,946
Gross Profit
228,114
205,344
144,587
39,354
9,625
Operating Expense
92,336
85,698
63,903
33,868
29,185
Operating Income
135,778
119,646
80,684
5,486
-19,560
Net Non Operating Interest Income Expense
5,144
4,434
4,397
604
517
Pretax Income
141,605
124,728
90,500
7,227
-18,222
Tax Provision
22,654
22,665
18,100
-154
1,662
Net Income Common Stockholders
118,951
102,063
72,400
7,381
-19,884
Diluted NI Available to Com Stockholders
118,951
102,063
72,400
7,381
-19,884
Basic EPS
2.02
1.73
1.23
0.12
-0.34
Diluted EPS
2.02
1.73
1.23
0.12
-0.34
Basic Average Shares
58,844.07
58,995.95
58,861.79
58,999.60
58,999.60
Diluted Average Shares
58,844.07
58,995.95
58,861.79
58,999.60
58,999.60
Total Expenses
137,988
129,387
100,759
59,121
44,131
Net Income from Continuing & Discontinued Operation
118,951
102,063
72,400
7,381
-19,884
Normalized Income
118,951
102,063
72,400
7,381
-19,884
Interest Income
5,184
4,475
4,401
604
517
Interest Expense
40
41
4
0
--
Net Interest Income
5,144
4,434
4,397
604
517
EBIT
141,645
124,769
90,504
7,227
-19,560
EBITDA
152,072
135,146
99,837
16,626
-10,224
Reconciled Cost of Revenue
45,652
43,689
36,856
25,253
14,946
Reconciled Depreciation
10,427
10,377
9,333
9,399
9,336
Net Income from Continuing Operation Net Minority Interest
118,951
102,063
72,400
7,381
-19,884
Normalized EBITDA
152,072
135,146
99,837
16,626
-10,224
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/21/2011

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers